The UK’s Central Laser Facility (CLF), operated by the Science and Technology Facilities Council (STFC), has achieved a primary target through the ultra-infrared laser system.
Open Access Government charts the recent policy priorities of Virginijus Sinkevičius, the European Commissioner for the Environment, Oceans and Fisheries, as Europe works towards a circular economy.
Mark Griffin, Hydrogen Market Development Manager for Clean Fuels, BOC, explains how to deploy hydrogen transport infrastructure to meet net-zero in this guide for councils.
Jarek Salek, Head of Engineering and Technical Operations at Uvisan, explains how UV-C cleaning in educational facilities can make shared equipment safe from COVID and help resume teaching that involves computers and other shared hardware.
Dave Sherwood, CEO and Founder at BibliU, explores the ways in which universities can improve student accessibility for those with a range of abilities and backgrounds.
Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.
Rob Walton, Industry Director - Public Sector, Six Degrees, discusses how the public sector must rebuild trust by implementing robust and flexible data security infrastructure.
Here, the team at SafeSite Security Solutions talk about Empty Property Rates and the recent decision by the Court of Appeal to dismiss a public interest challenge to a Government scheme for the mitigation of business rates on empty property.
Adrian Crawley, VP of Synack’s EMEA region, looks at the challenges ‘green’ measures place on cybersecurity protections, vehicle safety, data, city planning, personal information and payments and how a collaborative approach is needed to overcome them.
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
Dr. James E Goldman and Dr. Osama Al-Dalahmah from the Department of Pathology and Cell Biology at Columbia University, provide an in-depth perspective on Huntington’s disease (HD) research.
